Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis

Abstract The use of proton therapy (PT) in early-stage non-small cell lung cancer (ES-NSCLC) remains controversial, with insufficient evidence to determine its superiority over photon therapy (XRT). We conducted a systematic review of PT trials in ES-NSCLC, analyzing dosimetry, efficacy, and safety...

Full description

Bibliographic Details
Published in:Biomarker Research
Main Authors: Junyi He, Yingxin Liu, Xiaojing Zhang, Butuo Li, Linlin Yang, Haohua Wang, Shijiang Wang, Jinming Yu, Linlin Wang
Format: Article
Language:English
Published: BMC 2024-08-01
Subjects:
Online Access:https://doi.org/10.1186/s40364-024-00642-5